Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with cancer, confirmed by a tissue or cell sample test; some cancer types that can be identified by scans or specific markers (such as certain liver cancers or eye melanomas) may also qualify without a tissue or cell sample test.
- Your cancer has been treated with the goal of curing it (for example, through surgery, radiation, or chemotherapy), and that main treatment was finished within the last 12 months; if you are still taking ongoing supportive medicines like hormone therapy or immunotherapy, you may still be eligible as long as your main curative treatment ended within 12 months.
- You are 18 years old or older.
- You have read, understood, and signed the trial's consent form.
Who may not be able to join:
- You have had another active, serious cancer diagnosis within the past 2 years (though certain skin cancers or cancers considered fully cured with very low chance of return may be exceptions — confirm with trial site).
- You have previously received a stem cell transplant using cells donated by another person.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Lillian Siu, MD, Princess Margaret Cancer Centre
Phone: 437-676-6598
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To collect, annotate, and analyze biospecimens for the detection of MRD; To determine the prevalence of MRD over time across tumor types
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.